ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

INO Inovio Pharmaceuticals Inc New

10.38
0.255 (2.52%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Inovio Pharmaceuticals Inc New INO 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.255 2.52% 10.38 13:00:11
개장가 저가 고가 종가 전일 종가
10.25 10.09 10.70 10.57 10.125
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
16/04/202407:39PRNUSINOVIO Announces Pricing of Approximately $36 Million..
27/03/202407:28PRNUSINOVIO to Participate in The Citizens JMP Novel Therapeutics..
07/03/202406:05PRNUSINOVIO Reports Fourth Quarter and Full Year 2023 Financial..
06/03/202421:00PRNUSGeneos Therapeutics to Present New Clinical Data on..
06/03/202420:02IHMARKETNEWSU.S. Stock Futures Gain Ahead of Economic Insights; Oil..
21/02/202422:00PRNUSINOVIO to Report Fourth Quarter and Year-End 2023 Financial..
08/02/202401:46PRNUSINOVIO to Present at the Oppenheimer 34th Annual Healthcare..
02/02/202422:00PRNUSINOVIO Reports Inducement Grant Under Inducement Plan
01/02/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
27/01/202406:01EDGAR2Form S-3/A - Registration statement under Securities Act of..
26/01/202406:02EDGAR2Form 8-K - Current report
23/01/202422:00PRNUSINOVIO Announces Effective Date of 1-for-12 Reverse Stock..
22/01/202422:00PRNUSINOVIO to Participate in Virtual Fireside Chat on the..
13/01/202407:27EDGAR2Form 8-K - Current report
04/01/202422:00PRNUSINOVIO and Coherus Announce Clinical Collaboration to..
03/01/202422:00PRNUSINOVIO Plans to Submit a BLA for INO-3107 as a Potential..
29/11/202306:05EDGAR2Form DEF 14A - Other definitive proxy statements
18/11/202306:00EDGAR2Form PRE 14A - Other preliminary proxy statements
10/11/202306:35EDGAR2Form S-3 - Registration statement under Securities Act of..
10/11/202306:15EDGAR2Form 8-K - Current report
10/11/202306:05PRNUSINOVIO Reports Third Quarter 2023 Financial Results and..
10/11/202306:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202305:01EDGAR2Form 8-K - Current report
01/11/202321:00PRNUSINOVIO Reports Inducement Grants Under Inducement Plan
26/10/202321:00PRNUSINOVIO to Report Third Quarter 2023 Financial Results on..
11/10/202305:00EDGAR2Form 8-K - Current report
10/10/202323:51DJNInovio Shares Rise 8% After FDA Feedback for INO-3107
10/10/202321:00PRNUSINOVIO Receives FDA Feedback that Data from Completed Phase..
28/09/202308:39PRNUSGeneos Therapeutics Closes its Series A3 Financing With..
07/09/202321:00PRNUSINOVIO Announces U.S. FDA Breakthrough Therapy Designation..
29/08/202321:00PRNUSINOVIO to Present at the H.C. Wainwright 25th Annual Global..
10/08/202305:23EDGAR2Form 8-K - Current report
10/08/202305:05PRNUSINOVIO Announces Second Quarter 2023 Financial Results and..
10/08/202305:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/08/202321:00PRNUSINOVIO Reports Inducement Grants Under Inducement Plan
01/08/202310:43EDGAR2Form 8-K - Current report
26/07/202322:32PRNUSINOVIO to Report Second Quarter 2023 Financial Results on..
08/07/202305:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
04/07/202306:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/06/202305:10GLOBEINOVIO Announces Notice of Pendency and Proposed Settlement..
01/06/202321:00PRNUSINOVIO Reports Inducement Grants Under Inducement Plan
25/05/202321:00PRNUSINOVIO to Present at the 2023 Jefferies Healthcare..
24/05/202305:13PRNUSINOVIO Announces Orphan Drug Designation for INO-3107 for..
11/05/202305:05PRNUSINOVIO Reports First Quarter 2023 Financial Results and..
08/05/202321:00PRNUSNew Data from Phase 1/2 Trial of INO-3107 for the Treatment..
05/05/202321:00PRNUSINOVIO to Present at the 2023 RBC Capital Markets Global..

최근 히스토리

Delayed Upgrade Clock